GLUC Glucose Health, Inc.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1420108 · Fiscal year ends 12/31
Financial factors as of 2017-09-30 (2017Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-70.6%
TTM net income YoY73.8%
TTM EPS YoY—
Revenue 3-yr CAGR237.6%
Net income 3-yr CAGR—
Margins
Gross margin65.4%
Operating margin-36.8%
Net margin-96.5%
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-241.9%
ROIC (approx.)—
Asset turnover2.51x
Leverage & solvency
Liabilities / assets1,717.4%
Debt / equity—
Current ratio0.06x
Interest coverage-0.29x
Cash quality & payout
Operating cash flow / net income0.20x
Accruals ratio-192.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20162016-12-31 | FY20152015-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $313,229 | $4,272 |
| Cost of revenue | $294,062 | $3,875 |
| Gross profit | $19,167 | $397 |
| R&D expense | — | $48 |
| SG&A expense | $51,838 | $114,820 |
| Operating income | -$86,647 | -$156,173 |
| Interest expense | $323,796 | $120,028 |
| Pretax income | -$410,443 | -$266,064 |
| Net income | -$410,443 | -$266,064 |
| EPS (basic) | -0.15 | -0.14 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $20,542 | $2,055 |
| Receivables | $11,724 | $3,150 |
| Inventory | — | $8,370 |
| Current assets | $32,905 | $15,107 |
| Total assets | $33,145 | $15,407 |
| Current liabilities | $528,592 | $403,226 |
| Total liabilities | $528,592 | $403,226 |
| Shareholders' equity | -$495,447 | -$387,819 |
| Shares outstanding | 3.31M | 2.45M |
| Cash flow statement | ||
| Operating cash flow | -$39,263 | -$115,776 |
| Investing cash flow | $250 | -$250 |
| Financing cash flow | $57,500 | $113,210 |
| Stock-based compensation | $1,875 | $32,775 |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.